Table 4. Univariate and multivariate analyses for overall survival.
Factor | No. of patients | Univariate | Multivariate | ||
---|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | ||
Age | |||||
<80 | 207 | 1 | 1 | ||
≥80 | 57 | 1.44 (0.94–2.14) | 0.08 | 1.34 (0.85–2.06) | 0.20 |
Sex | |||||
Male | 174 | 1 | |||
Female | 90 | 1.12 (0.77–1.59) | 0.55 | ||
CCI | |||||
0 | 186 | 1 | |||
≥1 | 78 | 1.33 (0.92–1.90) | 0.12 | ||
TNM stage of solid tumor | |||||
II/III | 32 | 1 | 1 | ||
IV | 226 | 3.29 (1.65–7.80) | < 0.005 | 3.59 (1.80–8.52) | < 0.0001 |
ECOG-PS | |||||
0/1 | 215 | 1 | 1 | ||
2/3/4 | 48 | 2.53 (1.64–3.77) | < 0.0001 | 1.58 (0.98–2.49) | 0.06 |
G8 a | |||||
High score | 45 | 1 | 1 | ||
Intermediate score | 115 | 2.09 (1.17–4.02) | < 0.05 | 1.81 (1.00–3.52) | < 0.05 |
Low score | 104 | 3.48 (1.97–6.63) | < 0.0001 | 3.34 (1.85–6.47) | < 0.0001 |
Abbreviations: CI, confidential interval; CCI, Charlson comorbidity index; ECOG-PS, Eastern Cooperative Oncology Group performance status.
a: High score, intermediate score, and low score group had a G8 score of 14.5–17, 11–14, and 0–10.5, respectively.